Projects per year
Abstract
Familial hypertrophic cardiomyopathy (FHC) patients are advised to avoid strenuous exercise due to increased risk of arrhythmias. Mice expressing the human FHC-causing mutation R403Q in the myosin heavy chain gene (MYH6) recapitulate the human phenotype, including cytoskeletal disarray and increased arrhythmia susceptibility. Following in vivo administration of isoproterenol, mutant mice exhibited tachyarrhythmias, poor recovery and fatigue. Arrhythmias were attenuated with the β-blocker atenolol and protein kinase A inhibitor PKI. Mutant cardiac myocytes had significantly prolonged action potentials and triggered automaticity due to reduced repolarization reserve and connexin 43 expression. Isoproterenol shortened cycle length, and escalated electrical instability. Surprisingly isoproterenol did not increase CaV1.2 current. We found alterations in CaV1.2-β1 adrenergic receptor colocalization assessed using super-resolution nanoscopy, and increased CaV1.2 phosphorylation in mutant hearts. Our results reveal for the first time that altered ion channel expression, co-localization and β-adrenergic receptor signaling associated with myocyte disarray contribute to electrical instability in the R403Q mutant heart.
Original language | English |
---|---|
Article number | 11296 |
Pages (from-to) | 11296 |
Number of pages | 1 |
Journal | Scientific Reports |
Volume | 13 |
Issue number | 1 |
DOIs | |
Publication status | Published - Dec 2023 |
Fingerprint
Dive into the research topics of 'Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy'. Together they form a unique fingerprint.Projects
- 3 Finished
-
How does sudden cardiac death occur in familial hypertrophic cardiomyopathy?
Hool, L. (Investigator 01), Semsarian, C. (Investigator 02), Hill, A. (Investigator 03) & Viola, H. (Investigator 04)
NHMRC National Health and Medical Research Council
1/01/18 → 31/12/22
Project: Research
-
The L-type calcium channel in cardiovascular health and disease
Hool, L. (Investigator 01)
NHMRC National Health and Medical Research Council
1/01/17 → 31/12/21
Project: Research
-
A novel therapy for the prevention and treatment of familial hypertrophic cardiomyopathy
Hool, L. (Investigator 01), Semsarian, C. (Investigator 02) & Swaminatha Iyer, I. (Investigator 03)
NHMRC National Health and Medical Research Council
1/01/16 → 31/12/20
Project: Research